Description
TREN E 200 – Trenbolone Enanthate 200mg/ml
TREN E 200 provides 200mg/ml of Trenbolone Enanthate, a long-acting ester of one of the most powerful anabolic compounds available. It is engineered for athletes seeking significant improvements in raw strength, lean muscle growth, and metabolic efficiency over a sustained cycle duration.
Trenbolone Enanthate delivers pronounced anabolic effects without estrogenic conversion, making it ideal for achieving a dry, hardened look. It dramatically enhances nitrogen retention, red blood cell production, and protein synthesis, all while supporting fat reduction and promoting muscle preservation during intense training regimens.
Application:
Preferred for 8–12 week cycles by experienced users who aim for long-term physique enhancement and performance optimization. Best used in conjunction with testosterone and proper on-cycle support to mitigate potential side effects.
Important Note:
Due to its potency and long half-life, this compound is intended for advanced users only. Careful planning is required to maintain hormonal health and cardiovascular stability.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.